Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Matthay

Showing results (101-110 of 316) with videos related to

Pageof 32
Sort By:
Infection and Immunity|January 1, 1981
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayK K Matthay, W C Mentzer, D W Wara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemiaF E Halberg, J H Kramer, I M Moore, et al.
Nature Reviews. Disease Primers|November 11, 2016
NeuroblastomaKatherine K Matthay, John M Maris, Gudrun Schleiermacher, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
Cancer|June 22, 2011
Clinical features and outcomes in patients with extraskeletal Ewing sarcomaMark A Applebaum, Jennifer Worch, Katherine K Matthay, et al.
Medical and Pediatric Oncology|May 1, 1996
Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiographyP Lang, M Vahlensieck, K K Matthay, et al.
British Journal of Cancer|May 3, 2002
Daycare attendance and risk of childhood acute lymphoblastic leukaemiaX Ma, P A Buffler, S Selvin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Margaret J Zhou, Michelle Y Doral, Steven G DuBois, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2006
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of ageHideki Sano, Jeffrey Bonadio, Robert B Gerbing, et al.
Medical Physics|March 19, 2026
Simplified dosimetry using two-time-point kinetic modeling of <sup>124</sup>I-MIBG PET for <sup>131</sup>I-MIBG therapy in neuroblastomaYiran Wang, Yoonsuk Huh, Katherine K Matthay, et al.
Pageof 32

Showing results (101-110 of 316) with videos related to

Sort By:
Pageof 32
Infection and Immunity|January 1, 1981
Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assayK K Matthay, W C Mentzer, D W Wara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemiaF E Halberg, J H Kramer, I M Moore, et al.
Nature Reviews. Disease Primers|November 11, 2016
NeuroblastomaKatherine K Matthay, John M Maris, Gudrun Schleiermacher, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
Cancer|June 22, 2011
Clinical features and outcomes in patients with extraskeletal Ewing sarcomaMark A Applebaum, Jennifer Worch, Katherine K Matthay, et al.
Medical and Pediatric Oncology|May 1, 1996
Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiographyP Lang, M Vahlensieck, K K Matthay, et al.
British Journal of Cancer|May 3, 2002
Daycare attendance and risk of childhood acute lymphoblastic leukaemiaX Ma, P A Buffler, S Selvin, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Margaret J Zhou, Michelle Y Doral, Steven G DuBois, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2006
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of ageHideki Sano, Jeffrey Bonadio, Robert B Gerbing, et al.
Medical Physics|March 19, 2026
Simplified dosimetry using two-time-point kinetic modeling of <sup>124</sup>I-MIBG PET for <sup>131</sup>I-MIBG therapy in neuroblastomaYiran Wang, Yoonsuk Huh, Katherine K Matthay, et al.
Pageof 32